Zhonghong Pulin Medical Products Co., Ltd. (SHE:300981)
China · Delayed Price · Currency is CNY 13.08
-0.13 (-0.98%)
At close: Feb 13, 2026
SHE:300981 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | -145.37 | -87.13 | -130.87 | 66.92 | 2,342 | 2,664 |
Depreciation & Amortization | 218.59 | 218.59 | 206.54 | 147.87 | 80.25 | 59.66 |
Other Amortization | 3.92 | 3.92 | 0.71 | 0.27 | 0.01 | 0.03 |
Loss (Gain) From Sale of Assets | -0.85 | -0.85 | -0.87 | -0.43 | -3.18 | 0.06 |
Asset Writedown & Restructuring Costs | 175.63 | 175.63 | 99.92 | 12.12 | 18.38 | 0.07 |
Loss (Gain) From Sale of Investments | -56.26 | -56.26 | -94.09 | -69.56 | -82.54 | -4.85 |
Provision & Write-off of Bad Debts | - | - | - | - | -1.17 | 1.87 |
Other Operating Activities | -8.74 | 36.83 | 143.28 | 109.63 | 148.77 | 83.49 |
Change in Accounts Receivable | -74.59 | -74.59 | 32.88 | 61.69 | 572.85 | -647.05 |
Change in Inventory | -124.82 | -124.82 | -97.43 | -44.81 | -282.03 | -164.39 |
Change in Accounts Payable | 88.22 | 88.22 | -112.04 | -88.86 | -421.64 | 723.99 |
Change in Other Net Operating Assets | 5.06 | 5.06 | 8.09 | -54.52 | - | - |
Operating Cash Flow | 80.11 | 183.91 | 41.71 | 106.71 | 2,362 | 2,720 |
Operating Cash Flow Growth | - | 340.94% | -60.91% | -95.48% | -13.13% | 1375.02% |
Capital Expenditures | -160.97 | -107.4 | -103.17 | -207.65 | -978.56 | -429.43 |
Sale of Property, Plant & Equipment | 0.02 | 0.62 | 14.35 | 0.28 | 4.06 | 0.04 |
Cash Acquisitions | -109.88 | - | -580.56 | -35.09 | - | - |
Divestitures | - | - | - | - | - | 5.77 |
Investment in Securities | -865.93 | -485.15 | 773.93 | 102.91 | -3,186 | -378.52 |
Other Investing Activities | 45.33 | 78.05 | 100.97 | 64.33 | 41.62 | - |
Investing Cash Flow | -1,091 | -513.88 | 205.52 | -75.21 | -4,119 | -802.14 |
Long-Term Debt Issued | - | 976.97 | 507.8 | 225.25 | - | 198.09 |
Long-Term Debt Repaid | - | -610.68 | -195.01 | -153.58 | -108.26 | -420.46 |
Net Debt Issued (Repaid) | 496.35 | 366.28 | 312.79 | 71.67 | -108.26 | -222.37 |
Issuance of Common Stock | - | - | - | - | 1,918 | - |
Repurchase of Common Stock | -10.03 | -10.03 | -8.96 | - | - | - |
Common Dividends Paid | -120.49 | -215.94 | -294.64 | -501.28 | -252.07 | -587.47 |
Other Financing Activities | 15.54 | -1.33 | 30.8 | - | -24.63 | -0.6 |
Financing Cash Flow | 381.38 | 138.98 | 39.99 | -429.61 | 1,533 | -810.43 |
Foreign Exchange Rate Adjustments | 32.31 | 17.18 | 12.5 | 19.31 | -9.98 | -72.99 |
Net Cash Flow | -597.64 | -173.8 | 299.71 | -378.81 | -233.84 | 1,034 |
Free Cash Flow | -80.87 | 76.51 | -61.46 | -100.95 | 1,384 | 2,290 |
Free Cash Flow Growth | - | - | - | - | -39.57% | 6656.11% |
Free Cash Flow Margin | -3.26% | 3.11% | -2.92% | -6.42% | 28.19% | 47.93% |
Free Cash Flow Per Share | -0.19 | 0.18 | -0.14 | -0.23 | 3.52 | 7.12 |
Cash Income Tax Paid | - | -104.23 | -120.18 | -99.79 | 504.59 | 374.35 |
Levered Free Cash Flow | -505.98 | -54.66 | -264.65 | -124.14 | 428.97 | 1,880 |
Unlevered Free Cash Flow | -488.63 | -39.6 | -255.05 | -123.1 | 429.98 | 1,886 |
Change in Working Capital | -106.81 | -106.81 | -182.92 | -160.11 | -139.93 | -84.17 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.